According to phase 4 trial results, vedolizumab is safer and more effective as a treatment in early Crohn’s disease, compared to late Crohn’s disease.
This open-label, investigator-initiated, phase 4 cohort study enrolled 260 patients with…
Category: 6. Health
-
Impact of COVID-19 on pituitary function: a cross-sectional study in southern Iran | BMC Endocrine Disorders
Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514–23.
Continue Reading
-
Serum uric acid mediates the association between the estimated glucose disposal rate and chronic kidney disease in patients with diabetes or prediabetes: an analysis from NHANES 2005–2018 | BMC Endocrine Disorders
Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan B B, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.
Continue Reading
-
Just a moment…
Just a moment… This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation!
Continue Reading
-
Mexico City takes measures to improve community immunization coverage during winter season-Xinhua
A health worker prepares to administer a vaccine at a vaccination center in Mexico City, capital of Mexico, Nov. 12, 2025. Mexico City has set up a vaccination center offering influenza, COVID-19, pneumococcal and measles vaccines to the public…
Continue Reading
-
Early lean mass shapes long-term brain development in preterm infants
A new study reveals that the quality of early growth, not just weight gain, influences long-term brain outcomes for extremely preterm infants, highlighting fat-free mass as a crucial marker of early developmental health.
Study:
Continue Reading
-
New malaria treatments show promise as drug resistance grows
NEW YORK (AP) — Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to medication — one involving a new class of drugs.
Switzerland-based Novartis…
Continue Reading
-
Common gout drug shows promise in preventing heart attacks and strokes
A widely-used, inexpensive gout drug could reduce heart attacks and strokes in people with cardiovascular disease, according to a new Cochrane review.
The review examined the effects of low doses of colchicine, a drug used to treat…
Continue Reading
-
Collaborative effort advances next-generation therapies for pancreatic and GI cancers
Last year, researchers at the University of California, Riverside, developed a novel “molecular crowbar” strategy to degrade the oncogenic enzyme Pin1, a protein that is overexpressed in many tumors including pancreatic cancer….
Continue Reading
